Steven M. Larson
Impact in
- Radiology, Nuclear Medicine and Imaging top 0.01%
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Radiomics and Machine Learning in Medical Imaging
- Pulmonary and Respiratory Medicine top 0.02%
- Prostate Cancer Treatment and Research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 235
- Medical Imaging Techniques and Applications 133
- Monoclonal and Polyclonal Antibodies Research 87
- Radiomics and Machine Learning in Medical Imaging 46
-
- Prostate Cancer Treatment and Research 75
- Medical Imaging and Pathology Studies 43
- Co-authors
- John L. Humm (101 shared papers)Heiko Schöder (61 shared papers)Mithat Gönen (54 shared papers)Henry Yeung (42 shared papers)Yusuf E. Erdi (36 shared papers)Howard I. Scher (82 shared papers)Jorge A. Carrasquillo (87 shared papers)Ronald D. Finn (57 shared papers)
- Journals
- Journal of Clinical Oncology (68 papers)Journal of Nuclear Medicine (47 papers)European Journal of Nuclear Medicine and Molecular Imaging (20 papers)Nuclear Medicine and Biology (17 papers)Medical Physics (14 papers)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Steven M. Larson
704 papers receiving 44.3k citations
Steven M. Larson's Hit Papers
Peers
Comparison fields: 5 of 202
- Radiology, Nuclear Medicine and Imaging 19.0k
- Pulmonary and Respiratory Medicine 11.0k
- Oncology 9.0k
- Radiation 2.9k
- Endocrinology, Diabetes and Metabolism 4.7k
Countries citing papers authored by Steven M. Larson
This map shows the geographic impact of Steven M. Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Larson more than expected).
Fields of papers citing papers by Steven M. Larson
This network shows the impact of papers produced by Steven M. Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Larson. The network helps show where Steven M. Larson may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven M. Larson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 726 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study Hit paper breakdown → | 2010 | 846 |
| 2 | Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality Hit paper breakdown → | 2000 | 769 |
| 3 | Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe Hit paper breakdown → | 2014 | 605 |
| 4 | Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer Hit paper breakdown → | 2013 | 592 |
| 5 | Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. Hit paper breakdown → | 2006 | 571 |
| 6 | Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma Hit paper breakdown → | 2011 | 554 |
| 7 | Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer Hit paper breakdown → | 2007 | 548 |
| 8 | Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development Hit paper breakdown → | 2005 | 539 |
| 9 | Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 Hit paper breakdown → | 2003 | 532 |
| 10 | 1999 | 495 | |
| 11 | 2006 | 435 | |
| 12 | Radioimmunotherapy of human tumours Hit paper breakdown → | 2015 | 425 |
| 13 | 1997 | 424 | |
| 14 | 2008 | 420 | |
| 15 | 2002 | 392 | |
| 16 | 2005 | 389 | |
| 17 | 2007 | 375 | |
| 18 | 2010 | 355 | |
| 19 | 1985 | 353 | |
| 20 | Effect of respiratory gating on quantifying PET images of lung cancer. | 2002 | 353 |
About Steven M. Larson
Steven M. Larson is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism, having authored 726 papers that have together received 46.3k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (235 papers), Medical Imaging Techniques and Applications (133 papers), Monoclonal and Polyclonal Antibodies Research (87 papers), Prostate Cancer Treatment and Research (75 papers), Thyroid Cancer Diagnosis and Treatment (52 papers), Radiomics and Machine Learning in Medical Imaging (46 papers), Medical Imaging and Pathology Studies (43 papers) and Neuroblastoma Research and Treatments (42 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (19.0k citations), Pulmonary and Respiratory Medicine (11.0k citations), Oncology (9.0k citations), Radiation (2.9k citations) and Endocrinology, Diabetes and Metabolism (4.7k citations). Steven M. Larson has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include John L. Humm, Heiko Schöder, Mithat Gönen, Henry Yeung, Yusuf E. Erdi, Howard I. Scher, Jorge A. Carrasquillo, Ronald D. Finn, Richard J. Robbins and Pat Zanzonico. Their work appears in journals such as Journal of Clinical Oncology, Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Nuclear Medicine and Biology and Medical Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.